ACCOUNTS - Final Accounts

Registered number: 07904233

BOTTLED SCIENCE LTD

FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2025

BOTTLED SCIENCE LTD

COMPANY INFORMATION

Directors	C. Haig
	P. Raper
	R. Raper
	H. C. Porter


Registered number	07904233


Registered office	Unit 5 St Margaret's Business Park
	Drummond Place
	St Margarets
	Twickenham
	TW1 1JN

BOTTLED SCIENCE LTD

CONTENTS

	Page
Balance Sheet	1 - 2
Notes to the Financial Statements	3 - 9

BOTTLED SCIENCE LTD

REGISTERED NUMBER: 07904233

BALANCE SHEET

AS AT 31 DECEMBER 2025

		2025		2024
Note		£		£

Fixed assets
Tangible assets	4		473,806		524,629
Current assets
Stocks	5	270,488		290,790
Debtors	6	4,801,880		4,986,865
Bank and cash balances		64,856		172,531
		5,137,224		5,450,186
Creditors: amounts falling due within one year	7	(15,180,340)		(14,831,903)
Net current liabilities			(10,043,116)		(9,381,717)
Total assets less current liabilities			(9,569,310)		(8,857,088)
Creditors: amounts falling due after more than one year	8		-		(3,426)
Net liabilities			(9,569,310)		(8,860,514)

Capital and reserves
Allotted, called up and fully paid share capital	175	175
Profit and loss account	(9,569,485)	(8,860,689)
Equity shareholders' deficit	(9,569,310)	(8,860,514)

Page 1

BOTTLED SCIENCE LTD

REGISTERED NUMBER: 07904233

BALANCE SHEET (CONTINUED)

AS AT 31 DECEMBER 2025

The directors consider that the company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The company has opted not to file the Directors' Report and the Statement of Income and Retained Earnings in accordance with provisions applicable to companies subject to the small companies regime, under section 444 of the Companies Act 2006.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on
13 July 2026.

P. Raper

Director

The notes on pages 3 to 9 form part of these financial statements.

Page 2

BOTTLED SCIENCE LTD

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2025

1.	General information

Bottled Science Ltd (company number: 07904233), having its registered office and principal place of business at Unit 5 St Margaret's Business Park, Drummond Place, St Margaret's, Twickenham, TW1 1JN, is a private limited company incorporated in England and Wales.

2.Accounting policies

2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The following principal accounting policies have been applied:

2.2

Statement of Cash Flows

The company has taken advantage of the exemption in Financial Reporting Standard 102, section 1A.7 from the requirement to provide a Statement of Cash Flows on the grounds that it is a small company.

2.3

Going concern

At the Balance Sheet date, the company had net liabilities of £9,569,310 (2024: £8,860,514). The company relies on the support of the directors and its related parties who will continue to support the company for the foreseeable future. On this basis, the directors consider it appropriate to prepare the accounts on a going concern basis.

2.4

Turnover

Turnover is recognised to the extent that it is probable that the economic benefits will flow to the company and the revenue can be reliably measured. Turnover is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Sale of goods

Turnover from the sale of goods is recognised when all of the following conditions are satisfied:

∙the company has transferred the significant risks and rewards of ownership to the buyer;

∙the company retains neither continuing managerial involvement to the degree usually associated with ownership nor effective control over the goods sold;

∙the amount of revenue can be measured reliably;

∙it is probable that the company will receive the consideration due under the transaction; and

∙the costs incurred or to be incurred in respect of the transaction can be measured reliably.

Page 3

BOTTLED SCIENCE LTD

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2025

2.Accounting policies (continued)

2.5

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, using the straight-line method.

Depreciation is provided on the following basis:

Plant and machinery	-	10% straight-line
Motor vehicles	-	33.33% straight-line
Fixtures and fittings	-	25% straight-line
Office equipment	-	33.33% straight-line
Marketing assets	-	50% straight-line

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in the Statement of Income and Retained Earnings.

2.6

Leasing and hire purchase

Assets obtained under hire purchase contracts and finance leases are capitalised as tangible fixed assets. Assets acquired by finance leases are depreciated over the shorter of the lease term and their useful lives. Assets acquired by hire purchase are depreciated over their useful lives. Finance leases are those where substantially all of the benefits and risks of ownership are assumed by the company. Obligations under such agreements are included in creditors net of finance charge allocated to future periods. The finance element of the rental payment is charged to the Statement of Income and Retained Earnings so as to produce a constant periodic rate of charge on the net obligation outstanding in the report.

2.7

Stocks

Stocks are stated at the lower of cost and net realisable value, being the estimated selling price less costs to complete and sell. Cost is based on the cost of purchase on a first in, first out basis. Work in progress and finished goods include labour and attributable overheads.

At each Balance Sheet date, stocks are assessed for impairment. If stock is impaired, the carrying amount is reduced to its selling price less costs to complete and sell. The impairment loss is recognised immediately in the Statement of Income and Retained Earnings.

2.8

Debtors

Short-term debtors are measured at transaction price, less any impairment.

Page 4

BOTTLED SCIENCE LTD

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2025

2.Accounting policies (continued)

2.9

Financial instruments

The company only enters into basic financial instrument transactions that result in the recognition of
financial assets and liabilities like trade and other debtors and creditors, loans from banks and other
third parties and loans to related parties.

Financial assets that are measured at cost and amortised cost are assessed at the end of each
reporting period for objective evidence of impairment. If objective evidence of impairment is found,
an impairment loss is recognised in the Statement of Income and Retained Earnings.

For financial assets measured at cost less impairment, the impairment loss is measured as the
difference between an asset's carrying amount and best estimate of the recoverable amount, which
is an approximation of the amount that the company would receive for the asset if it were to be sold
at the Balance Sheet date.

2.10

Creditors

Short-term creditors are measured at the transaction price.

2.11

Foreign currency translation

Functional and presentation currency

The company's functional and presentational currency is British Pound Sterling (GBP).

Transactions and balances

Foreign currency transactions are translated into the functional currency using the spot exchange rates at the dates of the transactions.

At each period-end foreign currency monetary items are translated using the closing rate. Non-monetary items measured at historical cost are translated using the exchange rate at the date of the transaction and non-monetary items measured at fair value are measured using the exchange rate when fair value was determined.

2.12

Pensions

Defined contribution pension plan

The company operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the company pays fixed contributions into a separate entity. Once the contributions have been paid the company has no further payment obligations.

The contributions are recognised as an expense in the Statement of Income and Retained Earnings when they fall due. Amounts not paid are shown in accruals as a liability in the Balance Sheet. The assets of the plan are held separately from the company in independently administered funds.

Page 5

BOTTLED SCIENCE LTD

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2025

2.Accounting policies (continued)

2.13

Taxation

Tax is recognised in the Statement of Income and Retained Earnings.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the Balance Sheet date in the countries where the company operates and generates income.

Deferred tax balances are recognised in respect of all timing differences that have originated but not reversed by the Balance Sheet date, except that:

∙The recognition of deferred tax assets is limited to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits; and

∙Any deferred tax balances are reversed if and when all conditions for retaining associated tax allowances have been met.

Deferred tax balances are not recognised in respect of permanent differences. Deferred tax is determined using tax rates and laws that have been enacted or substantively enacated by the Balance Sheet date.

2.14

Finance costs

Finance costs are charged to the Statement of Income and Retained Earnings.

2.15

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours.

Employees

The average monthly number of employees, including directors, during the year was 16 (2024 - 19).

Page 6


		BOTTLED SCIENCE LTD

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025

Tangible fixed assets

	Plant and machinery	Motor vehicles	Fixtures and fittings	Office equipment	Marketing assets	Total
	£	£	£	£	£	£
Cost
At 1 January 2025	38,482	70,451	812,108	10,409	127,536	1,058,986
Additions	-	28,112	24,008	-	-	52,120
Disposals	-	(20,330)	-	-	-	(20,330)
At 31 December 2025	38,482	78,233	836,116	10,409	127,536	1,090,776
Depreciation
At 1 January 2025	38,122	70,451	322,016	5,433	98,335	534,357
Charge for the year	46	8,780	77,998	2,809	13,310	102,943
Disposals	-	(20,330)	-	-	-	(20,330)
At 31 December 2025	38,168	58,901	400,014	8,242	111,645	616,970
Net book value
At 31 December 2025	314	19,332	436,102	2,167	15,891	473,806
At 31 December 2024	360	-	490,092	4,976	29,201	524,629

Page 7

BOTTLED SCIENCE LTD

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2025

5.	Stocks
		2025	2024
		£	£

	Finished goods and goods for resale	270,488	290,790

Debtors

					2025	2024
					£	£

Due within one year
Trade debtors	850,454	804,517
Other debtors	3,765,669	4,036,064
Prepayments and accrued income	185,757	146,284
	4,801,880	4,986,865

7.	Creditors: Amounts falling due within one year
		2025	2024
		£	£

Obligations under finance lease and hire purchase contracts	890	890
Amounts owed to group undertakings	14,171,874	13,877,053
Trade creditors	297,669	248,105
Other taxation and social security	51,670	72,124
Other creditors	27,417	41,559
Accruals and deferred income	630,820	592,172
	15,180,340	14,831,903

8.	Creditors: Amounts falling due after more than one year
		2025	2024
		£	£

	Other creditors	-	3,426

9.	Pension commitments

The Company operates a defined contribution pension scheme. The pension costs for the year amounted to £13,403 (2024: £13,881). There were contributions totalling £3,997 (2024: £4,454) payable to the scheme at the year end included in other creditors.

Page 8

BOTTLED SCIENCE LTD

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2025

10.	Related party transactions
	Included within amounts owed to group undertakings are amounts due to companies with control over the Company of £14,171,874 (2024: £13,877,053). Included within other creditors are amounts due to key management personnel of the Company of £19,253 (2024: £19,253).

11.	Ultimate Parent Undertaking

As at 31 December 2025 and 31 December 2024, the ultimate parent undertaking is Atlantic Beauty
Limited, a company incorporated in Cayman Islands.

12.	Ultimate Controlling party

As at 31 December 2025 and 31 December 2024, the ultimate controlling party is Richard Raper, by
virtue of his control of Atlantic Beauty Limited, the Company's ultimate parent undertaking.

Page 9